Community/Retail

Over the past few months, I have described generalities associated with the concept of innovation by defining the terms, maintaining that this movement has staying power, and providing perspectives on how pharmacy remains opposed to it.

The 340B Program "mega-guidance" recently released by the Health Resources Services Administration (HRSA) sets stricter standards for contract pharmacy use.

Chris Hatwig, MS, FASHP of Apexus discusses how split billing software helps to keep contract pharmacies organized with respect to 340B requirements.

Chris Hatwig, MS, FASHP of Apexus discusses what HRSA policy updates, including 340B "mega guidance," are poised to affect health-system pharmacists.

It can be hard to motivate those who need the flu vaccine the most.

A list of the most debilitating diseases a patient may face over his or her lifetime was recently curated by Healthcare Business and Technology.

Kristen L. Marjama, DNP, MSN, FNP-BC, clinical educator with Healthcare Clinic at Walgreens in Fort Lauderdale, Florida, discusses strategies pharmacists can use to support asthma management.

Chris Hatwig, MS, FASHP of Apexus discusses how split billing software helps to keep contract pharmacies organized with respect to 340B requirements.

Eric A Wright, PharmD, MPH, investigator I for Geisinger Health Research, discusses the biggest factors that play a role in determining the likelihood that a patient will remain adherent to medications during care transitions.

Third-year pharmacy students at the Fairleigh Dickinson University (FDU) School of Pharmacy will soon attend sessions at The Medicines Company's patient simulation (Sim) lab.

The Kroger Co. family of stores is partnering with Feeding America and the country's dairy farmers and milk companies to encourage its shoppers to 'Pour It Forward' by donating nutrient-rich milk to families in need in their local communities.

Gregory Smith, PhD, has co-authored 14 technical papers and formal presentations and has been involved in informal presentations to clients and technologists on innovation and new product discovery.

The Convenient Care Association (CCA) is pleased to announce that Contemporary Clinic has become its official journal.

A generic equivalent to Bristol-Myers Squibb's entecavir (Baraclude) hepatitis B treatment has been approved by the FDA.

Jessica Kerr, PharmD, CDE, and assistant department chair at Southern Illinois University Edwardsville talks about information pharmacists should give patients on high-dose basal insulin.

In the recent past, bipolar disorder has been classified as the most costly mental illness.

Bartell Drugs has announced that Frank Segrave, President and CEO of Silvergate Pharmaceuticals and former Vice President of Pharmacy at Walmart, has joined the Bartell Drugs board of directors.

Community pharmacists have the opportunity to identify patients at risk for opioid overdose.

Reasor's has installed automated defibrillators in every store.

Company officials have announced that Food City will once again provide the flu vaccine this immunization season.

Recognition as a health care provider continues to be elusive for pharmacists.

PCSK9 inhibitors offer a new treatment option for patients with inherited conditions that cause high LDL cholesterol.

The Drug Enforcement Administration (DEA) recently made an appearance at a state pharmacy board meeting to appease pharmacists' fears of a crackdown on pharmacies.

As pharmacy students head back to school, an American Association of Colleges of Pharmacy (AACP) infographic offers an informative look at the state of pharmacy education.

Pharmacy technicians should know the following new drugs and expanded indications approved by the FDA in August 2015.

Rico Powell, CPhT, shares his thoughts on the pharmacy technician's growing role in ensuring patient safety and improving health care outcomes.

The FDA has proposed adding a 4-letter suffix to the names of biosimilars to distinguish them from their biologic counterparts.

Multidose medication dispensing at discharge (MMDD) involves supplying products that have been partially used during hospitalization to ensure continuity of care.